Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Isidro Villanueva"'
Autor:
Michelle Cornett, Scott B. Going, Jill Wright, Alex J. Zautra, Patrick E. McKnight, Isidro Villanueva, Shelley Kasle, Clara Streeter, Josh N. Farr
Publikováno v:
Arthritis Care & Research. 62:45-53
Objective To assess the relative effectiveness of combining self-management and strength training for improving functional outcomes in patients with early knee osteoarthritis. Methods We conducted a randomized intervention trial lasting 24 months at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2754295e79dfbeecfb56f4a29eec47
https://doi.org/10.1002/acr.20013
https://doi.org/10.1002/acr.20013
Autor:
Jimmy Cornelio Isidro Villanueva, Arnaldo Alejandro Ruiz Castro, Isidro Giraldo Jacinto Cornelio, Porfirio Baldomero Poma Rique
Publikováno v:
Aporte Santiaguino, Vol 1, Iss 1, Pp 19-25 (2008)
Aporte Santiaguino; Vol. 1, Núm. 1 (2008): Enero-Junio; pág. 19-25
Revistas-Universidad Nacional Santiago Antunez de Mayolo
Universidad Nacional Santiago Antúnez de Mayolo
instacron:UNASAM
Aporte Santiaguino; Vol. 1, Núm. 1 (2008): Enero-Junio; pág. 19-25
Revistas-Universidad Nacional Santiago Antunez de Mayolo
Universidad Nacional Santiago Antúnez de Mayolo
instacron:UNASAM
Se determinó que los factores ocupacionales como son, la condición laboral de los trabajadores, la ocupación, puesto de trabajo, las causas de los accidentes y estratos de la minería están relacionadas con la magnitud de los años de vida potenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015f911db71dc887a3dfe27c416ad387
http://revistas.unasam.edu.pe/index.php/AS_V10N2/article/view/324
http://revistas.unasam.edu.pe/index.php/AS_V10N2/article/view/324
Publikováno v:
The Cochrane Library
BACKGROUND: Adalimumab is a fully human anti-TNFalpha monoclonal antibody. Published studies indicate that its use in patients with RA can be effective and safe. OBJECTIVES: The aim of this review was to assess the efficacy and safety of adalimumab i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2229ec802d982cdf0b5c60b34491f6df
https://pubmed.ncbi.nlm.nih.gov/16034967
https://pubmed.ncbi.nlm.nih.gov/16034967
Autor:
Martin Berry, John Tesser, Oscar Gluck, Margaret D. Miller, Jeffrey R. Lisse, Neil M. Ampel, Christianne M. Yung, Julio Araujo, Isidro Villanueva, Dana M. Kageyama, James O. Posever, David E. Yocum, Linda Karl, Laurie Bergstrom
Publikováno v:
Arthritis and rheumatism. 50(6)
Objective To describe a group of patients who were treated with tumor necrosis factor α (TNFα) antagonists and who developed coccidioidomycosis, and to test the hypothesis that patients with inflammatory arthritis receiving TNFα antagonist therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc65f9a5e77a8329b0d2aebcbb217c8b
https://pubmed.ncbi.nlm.nih.gov/15188373
https://pubmed.ncbi.nlm.nih.gov/15188373
Autor:
Alex J, Zautra, David C, Yocum, Isidro, Villanueva, Bruce, Smith, Mary C, Davis, Jeanne, Attrep, Michael, Irwin
Publikováno v:
The Journal of rheumatology. 31(3)
We examined markers of immune activation during periods of stress and depressive symptoms in 45 female patients with rheumatoid arthritis (RA) in comparison to 106 controls with no autoimmune disease.Depressive symptoms were recorded, clinician ratin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06c9ceb9f26835042663847c111a004b
https://pubmed.ncbi.nlm.nih.gov/14994388
https://pubmed.ncbi.nlm.nih.gov/14994388
Autor:
Mats Björeman, Isidro Villanueva, Michele Intorcia, Veronique Halkin, Juan Luis Steegmann, Carine Cohen, Enrica Morra, Mauricette Michallet, Cosimo Paga, Gert J. Ossenkoppele, Thomas Kühr, Karin Cerri, David Marin Costa, Gregor Verhoef
Publikováno v:
Blood. 110:1959-1959
Current recommendations for patients with CML (Baccarani M, et al. Blood2006;108:1809–20) advocate regular treatment response monitoring, including evaluation of: cytogenetic response (CyR) at least every 6 months until complete CyR is achieved, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c193c7de72cb489a27ddca0673e941f
https://doi.org/10.1182/blood.v110.11.1959.1959
https://doi.org/10.1182/blood.v110.11.1959.1959
Autor:
Claire Cropet, Gregor Verhoef, Enrica Morra, Mats Björeman, Laurence Van Bree, Juan Luis Steegmann, Isidro Villanueva, Karin Cerri, David Marin Costa, Muriel Sterckx, Mauricette Michallet, Gert J. Ossenkoppele, Thomas Kühr
Publikováno v:
Blood. 110:1951-1951
Imatinib is widely used for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), and is associated with improved response rates in these patients. However, the management of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88a206395d6926353d6b82a1cd166b3f
https://doi.org/10.1182/blood.v110.11.1951.1951
https://doi.org/10.1182/blood.v110.11.1951.1951
Autor:
Laurie Bergstrom, David E. Yocum, Neil M. Ampel, Isidro Villanueva, Jeffrey Lisse, Oscar Gluck, John Tesser, James Posever, Margaret Miller, Julio Araujo, Dana M. Kageyama, Martin Berry, Linda Karl, Christianne M. Yung
Publikováno v:
Arthritis & Rheumatism; Jun2004, Vol. 50 Issue 6, p1959-1966, 8p